Midostaurin benefits

Midostaurin (Midostaurin) is a targeted therapy drug used to treat certain types of blood cancers, especially some subtypes in patients with acute myeloid leukemia (AML). The following are the main functions of midostaurin:

1.SuppressionFLT3Mutation: The main effect of midostaurin is to inhibit the abnormal activation of FLT3 (FMS-like tyrosine kinase3) receptor. FLT3mutations are relatively common in AML patients and are often associated with progression and relapse of the disease. Midostaurin can slow or stop the proliferation of leukemia cells, thereby extending patients' survival.

2.AMLTreatment: Midostaurin is mainly used to treat patients with acute myeloid leukemia (AML) who have FLT3 mutations, especially those who have received other treatments but still have relapse or are difficult to cure. The use of this drug helps control the growth of leukemia cells and improves survival rates.

3.Systemic mastocytosis (SM) treatment: Midostaurin is also used to treat systemic mastocytosis, a rare bone marrow mast cell disorder with cutaneous and systemic symptoms. It helps reduce symptoms and improve quality of life.

4.Non-Hodgkin lymphoma treatment: This drug is also used to treat a type of lymphoma called lymphocytic leukemia/Lymphoma-Associated protease phosphatase (Lymphoma-Associated Kinase, LAK)-mutated non-Hodgkin lymphoma.

Currently Midostaurin is not available in China, so patients cannot purchase it domestically. Midostaurin abroad is divided into original drugs and generic drugs. The cheaper original version is the Indian version, which costs more than 10,000 yuan. Others include Turkish and European original drugs, which cost tens of thousands to hundreds of thousands, which are relatively expensive. Generic drugs are mainly Indian generic drugs, which cost about several thousand yuan per box. They are much cheaper than the original drug, and the drug ingredients are basically the same as the original drug.